腎足蛋白(NPHN)單克隆抗體
Monoclonal Antibody to Nephrin (NPHN)
NPHS1; CNF; Nephrosis 1; Congenital Finnish Type; Renal glomerulus-specific cell adhesion receptor
- 編號MAA937Ra21
- 物種Rattus norvegicus (Rat,大鼠)相同的名稱,不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C2
- Ig亞型 IgG2b Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原RPA937Ra01-腎足蛋白(NPHN)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度1mg/ml
- 且適物種-
- 應(yīng)用IHC
如果抗體需用于流式細(xì)胞術(shù),請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 652 ¥ 1520¥ 2172¥ 5430¥ 21720
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對NPHN的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別NPHN。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Rattus norvegicus (Rat,大鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA937Ra01 | 腎足蛋白(NPHN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA937Ra01 | 腎足蛋白(NPHN)多克隆抗體 | WB; IHC; ICC; IP. |
MAA937Ra21 | 腎足蛋白(NPHN)單克隆抗體 | IHC |
SEA937Ra | 腎足蛋白(NPHN)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA937Ra | 腎足蛋白(NPHN)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA937Ra01 | 腎足蛋白(NPHN)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Yonsei medical journal | The Level of Serum and Urinary Nephrin in Normal Pregnancy and Pregnancy with Subsequent Preeclampsia.[pubmed:28120572] |
Experimental and molecular pathology | Alteration of Connexin43 expression in a rat model of obesity-related glomerulopathy.[pubmed:29246788] |
British Journal of Haematology? | Renal protection by atorvastatin in a murine model of sickle cell nephropathy[Pubmed:29527679] |
Journal of Clinical Medicine | Multiplex Bead Array Assay of a Panel of Circulating Cytokines and Growth Factors in Patients with Albuminuric and Non-AlbuminuricDiabetic Kidney Disease[Pubmed: 32961903] |
Disease Markers | Urinary Matrix Metalloproteinase-9 and Nephrin in Idiopathic Membranous Nephropathy: A Cross-Sectional Study[34707724] |
Biomed Rep | Early biomarkers of nephrotoxicity associated with the use of anti-VEGF drugs[Pubmed:35620307] |